Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation

BACKGROUND: Pretreatment plasma Epstein‐Barr virus (EBV) DNA is an important tumor marker and prognostic factor in nasopharyngeal carcinoma (NPC). This study aimed to clarify the relationship between plasma EBV DNA level and tumor burden. MATERIALS AND METHODS: Pretreatment tumor burden was measured...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Peng, Liang, Yang, Yi, Guo, Rui, Mao, Yan‐Ping, Xu, Cheng, Chen, Yu‐Pei, Sun, Ying, Ma, Jun, Tang, Ling‐Long
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308091/
https://ncbi.nlm.nih.gov/pubmed/30378277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1858
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky